Who's Who Legal
Who's Who Legal
New to Who's Who Legal?
New to Who's Who Legal?
Menu
User Menu
New to Who's Who Legal?
David M Eisenstadt

David M Eisenstadt

Ankura2000 K Street NW12th FloorWashingtonDistrict of ColumbiaUSA20006

Global Leader

Competition - Economists 2020

Professional Biography

WWL Ranking: Recommended

WWL says

David Eisenstadt is praised for his merger review expertise and his exquisite monopolisation analyses.

Biography

Dr David M Eisenstadt is a senior managing director at Ankura, based in Washington, DC. He is a nationally known economic expert in the fields of antitrust and industrial organisation, and has developed particular consulting and testimony expertise in the antitrust and industrial organisation analysis of health care markets. David’s experience, spanning more than 40 years, includes university teaching and employment as a senior economist at the US Department of Justice antitrust division. Since 1984, he has been employed in private economic consulting practice, including co-ownership of Microeconomic Consulting and Research Associates (MiCRA) from 1991 to 2015. Since 2015, he has been employed as a managing director in Navigant’s economics practice, acquired by Ankura in 2018.

David has provided expert testimony on issues related to competition in numerous industries including real estate brokerage services, professional sports, pharmaceuticals, electronics, tobacco products and health care markets. His testimony includes analyses pertaining to mergers, conspiracy, and matters involving monopolization and exclusionary conduct. During the course of his career he has analysed over several hundred provider mergers at different stages of review. Particular analyses in monopolisation cases have included testimony on market definition and alternative forms of conduct including market share discounts; discriminatory access; raising rivals’ costs; staff privilege and essential facility denials; most favoured nations agreements; and predation.

During his career, he has made numerous appearances before federal and state antitrust agencies and has testified in federal, state and administrative courts as an economic expert. Most recently, he testified in FTC v Advocate Health Care Network, Steward v Blue Cross Blue Shield of Rhode Island, and United Biologics et al v Allergy and Asthma Network/Mothers of Asthmatics et al. David has also testified in numerous non-antitrust commercial litigations, including disputes related to certificate of need review, trade secrets and other matters concerning theft of intellectual property. He has also computed economic damages in both antitrust and non-antitrust matters.

David has published articles in the areas of healthcare antitrust, vertical restraints, and the compilation of economic evidence in matters that are reviewed under a truncated rule-of-reason standard.

WWL Ranking: Recommended

WWL says

David Eisenstadt is celebrated as a senior statesman with over 40 years of experience in providing testimony and consulting advice in antitrust matters.

Biography

Dr David M Eisenstadt is a senior managing director at Ankura, based in Washington, DC. He is a nationally known economic expert in the fields of antitrust and industrial organisation, and has developed particular consulting and testimony expertise in the antitrust and industrial organisation analysis of health care markets. David’s more than 40 years of experience includes university teaching and employment as a senior economist at the US Department of Justice antitrust division. Since 1984, he has been employed in private economic consulting, including co-ownership of Microeconomic Consulting and Research Associates (MiCRA) from 1991 to 2015. Since 2015, he has been employed as a managing director in Navigant’s economics, acquired by Ankura in 2018.

David has provided expert testimony on issues related to competition in numerous industries including real estate brokerage services, professional sports, pharmaceuticals, electronics, tobacco products and healthcare markets. His testimony includes analyses pertaining to mergers; conspiracy; and matters involving monopolisation and exclusionary conduct. During the course of his career he has analysed several hundred provider mergers at different stages of review. Particular analyses in monopolisation cases have included testimony on market definition and alternative forms of conduct including market share discounts; discriminatory access; raising rivals’ costs; staff privilege; essential facility denials; most favoured nations agreements; and predation.

During his career, he has made numerous appearances before federal and state antitrust agencies and has testified in federal, state, and administrative courts as an economic expert. Most recently, he testified in FTC v Advocate Health Care Network, Steward v Blue Cross Blue Shield of Rhode Island and United Biologics v Allergy and Asthma Network/Mothers of Asthmatics. David has also testified in numerous non-antitrust commercial litigations, including certificate of need review, trade secrets, and other disputes relating to theft of intellectual property. He has computed economic damages in both antitrust and non-antitrust matters.

David has published articles in the areas of healthcare antitrust, vertical restraints, and the compilation of economic evidence in matters that are reviewed under a truncated rule-of-reason standard.

Law Business Research
Law Business Research Ltd
Meridian House, 34-35 Farringdon Street
London EC4A 4HL, UK
© Law Business Research Ltd 1998-2020. All rights reserved.
Company No.: 03281866